Abstract: Research report on the development of China's hemodialysis   Chinese Hospital Association Blood Purification Center Branch   
Corresponding author: WEI Tao, Email: weitao63@163.com 
【Abstract】Objective To investigate the current situation of hemodialysis in mainland China and provide references for the future national medical policies.  Methods  The number of maintenance hemodialysis patients and hemodialysis centers, as well as the manufacturing of hemodialysis industry were investigated in 31 provinces in mainland China using the methods of questionnaire survey, on-site survey and literature review.  Results  By the end of 2022, there were a total of 850, 809 maintenance hemodialysis patients and 7, 399 dialysis centers in mainland China. 26.1% of the hemodialysis centers belonged to tertiary hospitals, 61.6% belonged to secondary hospitals, and 8.5% belonged to primary hospitals or unclassified hospitals and 3.8% were not categorized. Public hospitals account for 84.9% of the hemodialysis centers, while private hospitals account for 15.1%. There were 30 registered blood purification equipment manufacturing companies in mainland China, including 12 foreign companies and 18 domestic companies, with Fresenius having the highest market share of 38%. There were 48 dialyzer manufacturing companies, including 17 foreign companies and 31 domestic companies, with Weigao having the highest market share of 30%. There were 14 manufacturers of hemoperfusion cartridge, including 3 foreign companies and 11 domestic companies, with Jianfan having the highest market share of 74%. There were 35 manufacturers of hemodialysis tubing, including 5 foreign companies and 30 domestic companies, with Weigao having the highest market share of 23%. There were 23 manufacturers of fistula puncture needles, with Nipro having the highest market share of 40%. There were 39 manufacturers of dialysate or hemodialysis dry powder. There were 31 manufacturers of water disposal equipment for hemodialysis, including 5 foreign companies and 26 domestic companies.  Conclusion  There are a large number of maintenance hemodialysis patients in mainland China. However, the hemodialysis centers are relatively insufficient and mainly distributed in secondary and tertiary hospitals, indicating enormous potential for the future development of hemodialysis. On the other hand, the core products of hemodialysis, such as dialysis equipment and dialyzers, rely mainly on foreign companies. Domestic companies should improve technology to be more competitive in the future.
【Key words】Hemodialysis; Current development; Survey; Market analysis

Key words: Hemodialysis, Current development, Survey, Market analysis